Scarica l'app Stockscreener
514.56
1.26%
-6.56
Dopo l'orario di chiusura:
516.21
1.65
+0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VRTX Giù?
Forum
Previsione
Frazionamento azionario
Vertex Pharmaceuticals Inc Borsa (VRTX) Ultime notizie
Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statement - Bitget
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Q2 Rundown: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs Other Therapeutics Stocks - Yahoo Finance
Vertex Pharmaceuticals (VRTX) executive gets 8,682-share stock grant - Stock Titan
Vertex (NASDAQ: VRTX) executive listed as insider with no reported shares - Stock Titan
Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs - Fierce Biotech
Vertex Pharma stock edges near 52-week high as pipeline expansion supports valuation - ad-hoc-news.de
Vertex at Wells Fargo healthcare conference: renal pipeline takes center stage - Investing.com
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vertex Pharma stock falls as market digests Crinetics deal and valuation risks - ad-hoc-news.de
Anti-kickback law at play, court tells Vertex as it schools HHS - bioworld.com
Where does Vertex Pharmaceuticals (NASDAQ:VRTX) fit within the Healthcare stocks conversation? - Kalkine Media
Vertex Pharmaceuticals: Solid Growth But Valuation Still Requires Flawless Execution - Seeking Alpha
Vertex Pharma stock heads into the open after a 3.1 percent drop - ad-hoc-news.de
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.06% on Sep 8: What Signal Does It Send? - TradingKey
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - The Motley Fool
Vertex Pharmaceuticals (VRTX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Why CRISPR Therapeutics Stock Rocked the Market Last Month - The Motley Fool
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Vertex Pharmaceuticals stock edges lower as market digests strong Q2 figures and insider selling - AD HOC NEWS
Vertex shares fall as investors digest Crinetics acquisition and related financing plans - Quiver Quantitative
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance
Could Nasdaq Focus Lift Attention on Vertex Pharmaceuticals (NASDAQ:VRTX)? - Kalkine Media
Vertex Pharmaceuticals stock steadies near a 52-week high - AD HOC NEWS
Why Vertex stock is sliding today - Wealth Awesome
Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Titan with 4.29% Upside and Robust Buy Ratings - DirectorsTalk Interviews
Vertex Pharma stock slips as revenue and EPS stay in view - AD HOC NEWS
Vertex makes some big people moves, completes its largest acquisition - The Boston Globe
Vertex Fertility Aid Plan Would Violate Kickback Law - Law360
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - The Motley Fool
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today - Benzinga
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout - Fierce Biotech
Is Vertex Pharmaceuticals (VRTX) Undervalued Following Casgevy’s FDA Label Expansion? - simplywall.st
Vertex Tops Citi’s Biotech Picks After Crinetics Deal Completion By Investing.com - Investing.com Canada
Fierce Biotech Layoff Tracker 2026: Novartis nixes Swiss site; TScan telegraphs 75% headcount drop - fiercebiotech.com
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex stock wins Overweight at Morgan Stanley (VRTX:NASDAQ) - Seeking Alpha
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? - Barchart.com
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report? - Yahoo Finance
Vertex Pharmaceuticals stock hits all-time high at $555.84 By Investing.com - Investing.com Canada
Vertex Pharmaceuticals stock hits all-time high at $555.84 - Investing.com India
Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Appoints Jonathan Poole as New Chi - GuruFocus
Crinetics Director Stephanie Okey Sells All Shares Following Vertex Pharmaceuticals Merger - Kalkine Media
Crinetics Director Wendell Wierenga Reports Stock Disposals Following Vertex Merger - Kalkine Media
Vertex buyout pays Crinetics (CRNX) insider in cash, but his options fared very differently - Stock Titan
Crinetics (NASDAQ: CRNX) director’s stock, options and RSUs all vest and turn to cash in Vertex buyout - Stock Titan
Crinetics (NASDAQ: CRNX) CCO awards vest, then are cashed out or wiped in $85-a-share Vertex merger - Stock Titan
Takeover hands Crinetics (CRNX) science chief an $85-a-share cash exit - Stock Titan
Vertex’s $85 deal cashes out Crinetics (NASDAQ: CRNX) awards - Stock Titan
Crinetics (CRNX) shareholders receive $85 per share as Vertex takeover closes - Stock Titan
Vertex (NASDAQ: VRTX) records new insider stock transaction - Stock Titan
Vertex Pharmaceuticals Incorporated Appoints Jonathan Poole as Executive Vice President, Effective January 1, 2027 - marketscreener.com
Vertex Pharmaceuticals (VRTX) Could Be 3% Undervalued If Its Pipeline Growth Holds - Yahoo Finance
Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform - Yahoo Finance
Vertex Completes $10 Billion Acquisition of Crinetics at $85 Per Share - Minichart
Vertex Names Jonathan Poole Finance Chief as Crinetics Buy Closes - marketscreener.com
Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition - marketscreener.com
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team - Business Wire
Vertex (NASDAQ: VRTX) director gifts 6,000 shares - Stock Titan
Shareholder approval clears way for Crinetics (NASDAQ: CRNX) sale to Vertex - Stock Titan
1.78%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):